(What’s Left of) Our Economy: An Omicron Bump in the US Manufacturing Recovery

Tags

aircraft, aircraft parts, automotive, CCP Virus, chemicals, coronavirus, COVID 19, facemasks, Federal Reserve, machinery, manufacturing, masks, medical devices, miscellaneous durable goods, monetary policy, non-metallic mineral products, Omicron variant, personal protective equipment, petroleum and coal products, pharmaceuticals, plastics and rubber products, PPE, printing, semiconductor shortage, semiconductors, stimulus, ventilators, wood products, Wuhan virus, {What's Left of) Our Economy

The big takeaway from today’s Federal Reserve after-inflation U.S. manufacturing data (for December) is that it may show domestic starting to suffer from the arrival into America of the super-infectious Omicron strain of the CCP Virus and the renewed economic curbs and behavioral changes it’s spurring, along with the spread of vaccine mandates in the ranks of U.S. businesses (of course, before yesterday’s Supreme Court decision striking down such policies for the private sector).

And especially discouraging: Just as Omicron began taking off, inflation-adjusted domestic output of medical equipment and supplies – including all the protective gear and treatment devices needed to fight the virus – fell sequentially at its fastest rate since the worst of the spring, 2020 pandemic-induced depression. Indeed, monthly real production in this category is now lower than in February, 2020 – the last full data month before the virus’ first variant began distorting the U.S. economy.

December’s 0.28 percent monthly decline in price-adjusted American manufacturing output represented industry’s first sequential retreat since September’s (hurricanes-affected) 0.52 percent drop. But the solid growth of recent months stayed largely unrevised.

The December results (which will remain preliminary for several more months) brought 2021’s yearly improvement in inflation-adjusted manufacturing output to 3.71 percent. That’s the best growth since 2011’s 6.48 percent, but as known by RealityChek regulars, it’s important to look at possible baseline effects nowadays. And this strong performance in part reflected the virus-fostered 1.94 percent fall-off in such growth in 2020.

The December downturn stemmed in part from problems (like the global semiconductor shortage) in the automotive sector, which shrank on month by 1.29 percent – following sequential expansion in November of a downwardly revised 1.69 percent. But even without the drag from vehicles and parts, domestic industry’s constant dollar production would still have been off by 0.22 percent.

Aside from automotive, the most important December real manufacturing growth loser by far was miscellaneous durable goods – a category that includes those pandemic-fighting essential medical devices and equipment industries. Its price-adjusted output slumped by 2.68 percent – the biggest downturn since April, 2020’s18.43 percent, during the worst of the CCP Virus’ first wave. Even so, measured by real production, the sector is 2.49 percent larger than in February, 2020, right before the pandemic’s initial major economic impact.

Other big December losers included:

>printing and related support activities, whose 1.82 percent slide was also the worst since April, 2020 (23.94 percent), and whose real output is now down by 5.14 percent since February, 2020;

>plastics and rubber products, whose 1.78 percent decrease was the worst since April, 2020 as well (19.12 percent), but that also followed seven months of strong gains. As a result, its real production is off just 1.08 percent since February, 2020; and

>petroleum and coal products, whose 1.58 percent fall-off was its worst since February’s seven percent, and whose after-inflation production is 4.49 percent lower than in February, 2020.

The biggest December winners were:

>non-metallic mineral products, which not only generated a 1.49 percent increase, but whose November inflation-adjusted output advance was revised all the way up from 1.25 percent to 3.03 percent. All the same, this sector’s constant-dollar production is still 1.32 percent lower than in February, 2020;

>wood products, whose 1.18 percent real increase in production was its best since March’s 4.05 percent, and which is now 3.03 percent bigger by this measure since February, 2020;

>the big chemicals sector, where real growth hit 0.69 percent following an upwardly revised 0.65 percent in November (from 0.50 percent), and which has grown by 7.93 percent in real terms since just before the pandemic; and – most encouragingly –

>machinery, a manufacturing bellwether because its products are so widely used throughout both industry and big non-manufacturing sectors like construction and agriculture – not to mention many services sectors. Its price-adjusted output increased by 0.68 percent sequentially in December – its best such result since July’s 2.85 percent, and revisions were unchanged on balance. Machinery production is now 5.20 percent higher than in February, 2020.

As for manufacturing industries that have been prominent in the news during the pandemic, they had a lousy December generally.

Aircraft and parts saw its monthly output down by 0.38 percent, and in stunning news, November’s initially reported 1.90 percent increase is now judged to be a 1.04 percent decrease. With October’s after-inflation production rise downgraded, too, aircraft and parts output is now just 10.71 percent higher than in February, 2020. As of last month’s Fed manufacturing data, this figure was a much higher 15.86 percent.

In pharmaceuticals and medicines, December’s 0.13 percent real output dip was the third straight monthly decline, and November and October revisions were fractionally negative on balance. Consequently, in price-adjusted production terms, these sectors were 13.42 percent larger than in February, 2020 – as opposd to the 13.54 percent calculable from last month’s industrial production report.

And as mentioned at the outset, the December results for medical equipment and supplies sector were awful – especially considering that for the next few months at least, Omicron’s metastasis will greatly increase demand for face masks, protective gowns, ventilators, and the like.

Real production of these products tumbled seqentially by 2.75 percent – the worst such performance since April, 2020’s 15.97 percent, during that first CCP Virus wave. Revisions for November and October were mildly positive, but whereas last month’s report revealed that inflation-adjusted production in these sectors was up since just before the first wave struck in force (though by a bare 0.65 percent), it’s now down by 1.50 percent. 

And let’s add another sector to the pandemic industries list – semiconductors and related devices. As implied by the category name, the numbers include more than the microchips that have been in such global short supply in recent months – and whose U.S. production revival has been such a high stated Washington, D.C. policy priority.

Still, it’s noteworthy that constant dollar output in this grouping rose a mere 0.12 percent on month in December, But it is up 16.86 percent since the pre-pandemicky February, 2020.

So far, betting against domestic manufacturing during the virus era has been a losing bet, But the headwinds for the near future at least look especially strong, topped of course by the spread of Omicron not only in the United States but in all the countries to which its manufacturers sell exports. Add to the list the apparent death of President Biden’s Build Back Better bill – which whatever its long-term economic wisdom and other effects, will certainly reduce government support for domestic economic activity – what seems like greater odds of more monetary policy tightening by the Federal Reserve sooner rather than later; and inflation that might be getting high enough to dampen U.S. consumer outlays.  

Tailwinds are by no means absent – like the beginning of spending made possible by the infrastructure bill, the still considerable amount of stimulus being provided by the Fed, and the easing of global supply chain knots. But even this last depends heavily on the medical, regulatory, and behavioral effects of Omicron in the United States and, perhaps even more important, in China, where the regime’s Zero Covid policy looks like a formula for ever broader lockdowns that will paralyze its ports and other infrastructure systems. 

Domestic manufacturers keep telling major surveys that they remain optimistic about the future.  (See here and here for the latest soundings.)  If anything’s certain about the circumstances they’re heading into, it’s that they’ll need every bit of this optimism to keep succeeding. 

Im-Politic: Omicron Looks Fairly Mild – Except Against a Key Biden Virus Claim

Tags

Anthony S. Fauci, Biden, Biden administration, CCP Virus, CDC, Centers for Disease Control and Prevention, coronavirus, COVID 19, hospitalization, Im-Politic, Omicron variant, vaccination, vaccines, Wuhan virus

I was struck by the statement made by Anthony S. Fauci on Tuesday that the Omicron variant of the CCP Virus is so hyper-infectious that it will “ultimately find just about everybody.” I wasn’t struck by the words of President Biden’s chief medical adviser because Omicron has found me healthwise. Instead, I was struck because the pandemic keeps finding my blogging – even when I don’t intend to write about it.

And so it’s been today. I started out planning to post an item about the Ukraine crisis and globalization (which I will definitely turn to), but Mr. Biden’s latest virus-related remarks have jerked me right back to the pandemic. Specifically responsible was his claim that unless many more Americans become fully vaccinated, Omicron’s rapid spread will mean that the nation’s hospitals will be crowded with resisters who contract unusually severe cases, leaving “little room for anyone else who might have a heart attack or an injury in an automobile accident or any injury at all.”

This point makes perfect sense. Even if Omicron’s effects are relatively mild for most victims, if the absolute numbers of cases are high enough, even a relatively small percentage of infections serious enough to require hospitalization would be enough to overwhelm the hospital system. And if, as Mr. Biden and so many others insist, the overwhelming majority of those hospitalized are unvaccinated individuals, then the case for mandatory vaccination would look open and shut.

But to use one of the President’s favorite phrases, “Here’s the deal.” Even if every American was fully vaxxed and boosted, if Fauci is right about Omicron’s eventual reach, then the hospital system will get overwhelmed anyway. Just do the math.

The whole U.S. population is a little above 330,000,000. If everyone gets Omicron, that’s 330,000,000 cases. How many are resulting in hospitalizations? The President says that unvaccinated Americans are “seventeen times more likely to get hospitalized” from the CCP Virus than the vaxxed.

This figure seems to come from the latest data kept by the U.S. Centers for Disease Control and Prevention (CDC), which finds that for every 100,000 American adults, 67.8 “Covid-19-Associated Hospitalizations” take place each week, versus a rate of only 3.9 hospitalizations for the fully vaccinated. That’s a big difference. But if you project those numbers out to the full 330,000,000 population rather than a sample of 100,000, you get 12,870 fully vaxxed hospitalizations each week.

That figure is a lot smaller than the number of “staffed (operational) acute care beds” in America (534,964, according to the latest count from the American Hospital Association). It’s also a lot smaller than the number of intensive care unit beds (96,5960).

But all by itself, it seems to be enough greatly to stress the heathcare system, given that (as the President noted), it’s got many other responsibilities; given that the 12,870 figure represents the number of new hospital patients added each week; and given that many of these fully vaxxed CCP Virus patients are going to stay hospitalized for a certain period even as new patients in this category keep coming in. 

At the same time, the CDC data on fully vaxxed Covid hospital patients surely creates an understatement for one big reason: They only go up to the week of last November 20. Therefore, they predate the recording of the first U.S. Omicron case (last December 1.)

The United States still lacks comprehensive nation-wide statistics on Omicron-related hospitalizations of the fully vaxxed. But some preliminary numbers indicate that their impact on hospitals will be catastrophic. For example, for the week of last December 27 (more than a month after the latest CDC numbers but just as the first Omicron case was reported), New York State found that 4.59 out of every 100,000 city residents who had been fully vaccinated were hospitalized for the CCP Virus.

That’s a positively infintestimal number. But multiply it out by the total 330,000,000 U.S. population, and that’s more than 1.5 million virus-related hospitalizations of the fully vaxxed. And even if you doubt that these numbers would hold for the entire country (because the United States is big and diverse), a breakthrough hospitalization rate only half that high would still produce more than 750,000 such cases.    

Some more recent figures are even more alarming. As of January 6, the Las Vegas, Nevada area experienced 27,205 breakthrough virus cases (e.g., number of infections of the fully vaxxed), of which 873 were hospitalized. That’s 3.21 percent. Ohio’s official Covid-19 dashboard says that of 53,819 state residents counted as “Covid-19 Hospitalizations,” since January 1, 2021, 2,991 have been  fully vaccinated. That’s 5.56 percent.

According to this January 6 post, in Connecticut, “The overall percentage of fully vaccinated people hospitalized with COVID has also risen to 32 percent, from about 20 percent early last week.”

Massachusetts has reported that as of early January, the state’s hospitals were treating 2,970 patients with confirmed cases of the CCP Virus. Of these, 1,348 were fully vaccinated. That’s more than 45 percent!

In fact, once again, if these numbers are too high by a factor of two, they still add up to overwhelmed hospital systems.

Help is on the way in the form of recently approved treatments (though it looks like due to Biden administration shortsightedness or caution, they’ll be kind of scarce for several months), and in the distinct possibilities that the Omicron wave will crest sooner rather than later, and that follow-on virus strains will be even less virulent. What’s more certain is that Omicron is making a complete – and unnecessarily divisive – mockery of Mr. Biden’s continuing “pandemic of the unvaccinated” claims.

(What’s Left of) Our Economy: The Transitory Inflation Story Endures

Tags

CCP Virus, consumer price index, core inflation, coronavirus, COVID 19, CPI, energy prices, Federal Reserve, food prices, inflation, Jay Bhattacharya, Jerome Powell, lockdowns, mandates, shortages, stimulus, supply chains, vaccine mandates, Wuhan virus, {What's Left of) Our Economy

Rather than presenting a good news/bad news story, today’s official U.S. figures on one key measure of inflation (bringing the story through December) put into pretty clear focus an important old news/new news story. And its main implication is that the current version of lofty inflation looks considerably different from the standard versions that have hit the nation previously. Therefore, it’s looking more “transitory” (at least in terms of stemming mainly from developments specific to the CCP Virus epidemic) than ever.

This distinction of course matters because evaluating the nature of today’s inflation will greatly influence how American policymakers (especially the Federal Reserve) respond, and how they should respond. If today’s price increases stem from standard sources, then a standard response – tighter monetary policy, less government spending – make sense. If current inflation is distinctive, more austere economic policies stil may be needed for any number of reasons, but inflation-fighting won’t be a strong one.

The new news? The U.S. government tracks two main measures of inflation: Overall price increases, and price increases for “core” goods and services. The latter gauge strips out food and energy prices – because ordinarily they’re supposed to be extraordinarily volatile for reasons mainly unrelated to the economy’s underlying inflation prone-ness.

But today’s inflation data (for what’s called the Consumer Price Index, or CPI), demonstrates that during the virus era, the core price increases have been more volatile than their overall counterparts.

Let me make clear two crucial points right at the outset, though: First, as I’ve written previously, “transitory” (a term used for months but “retired” recently by the Federal Reserve) doesn’t necessarily mean “short-lived.” That’s because the virus itself and its effects may well not be short-lived. Indeed, because of the unusually rapid spread of the Omicron variant, pandemic-related and inflation-fueling economic disruptions could well last for months more.

Second, viewing today’s inflation as transitory doesn’t mean that the Biden administration and Congress may not have made a serious mistake in supporting a major round of economic stimulus earlier this year – and therefore greatly boosting Americans’ spending power while the amount of goods and services remained limited for all sorts of (CCP Virus-related and other) reasons.

At the same time, precisely because the last stimulus bill was explicitly linked to the the pandemic’s effects, because the infusion of new money has been running out, and because President Biden’s Build Back Better bill looks pretty dead in Congress, this fiscal policy mistake’s effects are looking transitory, too.

Don’t forget, moreover, the immense monetary policy support for the economy provided by the Fed. It’s virus-related, too, and yesterday, Chair Jerome Powell made clearer than ever his view that the case for such emergency assistance no longer holds, and that the central bank’s decision to start withdrawing it is firmly on track.

In addition, some of the old news (at least for RealityChek readers) about today’s inflation still holds – and further reenforces the case for “transitory-ness.” And this old news concerns the baseline effects phenomenon – by which unusual results recorded at the beginning of a period of time in which comparisons are made exercise powerful, but intrinsically, misleading results at the end of that period. In this instance, the unusually low annual inflation numbers of 2019-2020 have been bound to play a significant role in generating abnormally strong increases for 2020-2021. (BTW, savvy investors take these baseline effects into account when evaluating stock performance, too. Just Google “easy comps.”)

Nevetheless, even this old news now reflects some of the new news. Meaning that for overall inflation, the baseline effect is fading and will continue to fade for the next two data months. For the core, however, the baseline effect will stay strong through March.

The month-by-month and year-by-year figures for both overall and core CPI illustrate all of these points nicely. First, let’s review the monthly changes in overall CPI for this calendar year:

Dec-Jan:                          0.26 percent

Jan-Feb:                          0.35 percent

Feb-March:                     0.62 percent

March-April:                  0.77 percent

April-May:                     0.64 percent

May-June:                      0.90 percent

June-July:                      0.47 percent

July-Aug:                      0.27 percent

Aug-Sept:                      0.41 percent

Sept-Oct:                      0.94 percent

Oct-Nov:                       0.78 percent

Nov-Dec:                      0.47 percent

That new December figure represents both the smallest such increase since July, and a big slowdown from November. So that’s a noteworthy sign of transitory-ness right there.

Yet on a monthly basis, as shown below, core inflation actually quickened a bit in December:

Dec-Jan:                      0.03 percent

Jan-Feb:                       0.10 percent

Feb-March:                  0.34 percent

March-April:                0.92 percent

April-May:                   0.74 percent

May-June:                    0.88 percent

June-July:                     0.33 percent

July-Aug:                     0.10 percent

Aug-Sept:                    0.24 percent

Sept-Oct:                     0.60 percent

Oct-Nov:                     0.53 percent

Nov-Dec:                    0.55 percent

A closer look, however, shows that the core’s ups and downs have been greater than that for overall inflation, and that was especially true early in the pandemic. From January through April, it skyrocketed from 0.03 percent to 0.92 percent, whereas overall price increases went up more slowly (though still impressively), from 0.26 percent to 0.74 percent.

Similar increase patterns are revealed in the annual overall and core inflation increases, but the volatility trends are somewhat different. First, the overall data:

Jan:                             1.37 percent

Feb:                            1.68 percent

March:                       2.64 percent

April:                         4.16 percent

May:                          4.93 percent

June:                          5.32 percent

July:                           5.28 percent

Aug:                           5.20 percent

Sept:                          5.38 percent

Oct:                            6.24 percent

Nov:                           6.88 percent

Dec:                           7.12 percent

Here the nation has experienced not only accelerating annual inflation, but a fourth straight month of acceleration.

Ditto for annual core inflation:

Jan:                            1.40 percent

Feb:                            1.28 percent

March:                       1.65 percent

April:                         2.96 percent

May:                          3.80 percent

June:                          4.45 percent

July:                          4.24 percent

Aug:                          3.98 percent

Sept:                          4.04 percent

Oct:                           4.58 percent

Nov:                          4.96 percent

Dec:                           5.49 percent

But rather than being more volatile early in the pandemic period, these prices sung the most between last June and September, and during December. Still, if the volatility of overall and core inflation have been in the same ballpark lately, that’s an indication that this most recent burst of inflation has broken the mold.

The baseline effects are also signaling the recent outsized volatility of core inflation. Since it was so unusually depressed early in the first pandemic year 2020, these effects, as mentioned above, will stay prominent in January and February, too. But the baseline effect for regular inflation is already fading and will continue on that path. 

As has been the case for nearly two years now, however, the wild card remains the CCP Virus and now its Omicron variant and even more particularly, government reactions to its stunning transmissability. Moreover, it’s not just the Biden administration that may contribute to inflation-boosting supply chain bottlenecks and shortages due to vaccine mandates, other curbs, and their impact on individual fears and behavior. China’s ongoing Zero Covid policy looms as a major threat, too.     

All of which brings up a point made by Stanford University medical school professor Jay Bhattacharya, a leading public health authority. He’s repeatedly written that “The end of the pandemic is primarily a social and political decision” because although “we have no technology to eradicate the virus,”`the knowhow and strategies for reopening safely and sustainably are already available. If, as I believe, he’s right, then ending virus-induced inflation and making it truly transitory is well within reach, too.  

 

Im-Politic: Covid Derangement Syndrome

Tags

CCP Virus, CDC, Centers for Disease Control and Prevention, coronavirus, COVID 19, health care, hospitals, Im-Politic, mask mandate, masks, Omicron variant, Politico, vaccine mandates, vaccines, Wuhan virus

If there’s emerged an Exhibit A as to how completely incoherent the nation’s public health establishment and medical systems have become on dealing with the CCP Virus (including its super-infectious but generally mild and often asymptomatic Omicron variant), it’s an article yesterday in Politico headlined “Health care workers are panicked as desperate hospitals ask infected staff to return.”

As is so often the case, moreover, this virus-related trend and its fallout has been reported without any allusions to the incoherence. And practically all of the muddle is expressed in the very first paragraph, starting with the very first half of the very first sentence:

“While most health workers are vaccinated, many are still falling sick, exacerbating a staff shortage as more Americans seek hospital care. The reliance on employees who may still be infectious comes despite objections from nurses‘ unions and the American Medical Association, which warned the decision puts patients’ health and safety at risk. And there are no requirements that patients be notified if their caregiver is sick.”

Presumably, when reporter Rachael Levy writes that “most health workers are vaccinated,” she means “fully vaccinated” – including boosters. Yet “many are still falling sick.” Readers never learn how many or, more important, what percentage. But it’s no doubt lots – indeed, enough to create and worsen staff shortages.

That alone should blow a big hole in the various sweeping “vaccines work” claims used, notably, to justify mandates for the jabs, especially since these health care workers by definition must overwhelmingly be individuals young enough and free enough of the special medical conditions to be able to avoid illness serious enough to render them too infeebled to report to work — much less to threaten grave illness or death.

But the headline indicates that the concern of the “panicked” health care workers isn’t simply that the colleagues who believe they should be staying home are crawling in, uncontrollably shedding pathogens and threatening staff and patients alike, and/or are physically incapable of performing their duties adequately.

They’re also concerned that these colleagues are “infected” in the first place.

Yet these worries are loopy for any number of glaringly obvious reasons. For example, if infected health care workers are asymptomatic, they should be fully capable of doing their jobs. In addition, the evidence so far seems to show that most virus victims don’t spread the pathogen (see, e.g., here and here), and when they do, they’re most contagious very early in their infections.

That last point is crucial because it’s behind the latest guidance for health care facilities issued by the U.S. Centers for Disease Control and Prevention (CDC). As Levy (thankfully!) reports, this advisory allows such providers “to bring back workers after five days of isolation, instead of 10, without a negative Covid-19 test.” What’s more, “In cases where workforce shortages become extreme, hospitals can bring back staff without any isolation period.”

Stranger still: Presumably the health care workers who so fear their supposedly irresponsible colleagues are, according to their own definitions, behaving very responsibly themselves. In other words, they’re surely individuals who are both fully vaccinated and dedicated mask-wearers.

If they’re vaccinated, of course, it’s now clear that their protection against infection is far from perfect, but that their protection against severe illness and death is very good. That is, if they do get infected, and since they are young-ish and strong-ish, they’ll recover fully and pretty quickly — assuming they experience any symptoms at all.

Further, since they work in hospitals, they’re almost certainly also wearing the kinds of masks that are highly effective in preventing infection, not the cloth masks worn so widely outside hospitals that even the CDC has found provide pretty ineffective protection. So have the worried workers now joined the “vaccines and many masks don’t work at all” camp?

It’s true that the Omicron variant may be a virulent enough spreader to confound both vaccines and boosters and even high quality masks, at least to a significant degree. But if this is the case, to date, the health effects of Omicron spread look much too weak to justify panic or even close for anyone without specific vulnerabilities.

Yes, hospitals are full of people with such vulnerabilities – the patients. But the CDC guidelines contain recommendations for dealing with them.

Not that the CDC has covered itself with glory throughout the pandemic. Or that this specific approach that it’s taken to the health care system will keep everyone involved fully protected.

But as one hospital CEO quoted by Levy reminds, “We don’t have good choices — or the choices that we want.” A new consensus seems to be emerging in the nation that America has to “learn to live” with the CCP Virus. Unless it’s believed that somehow the health care delivery system should be an exception (and should be crippled until somehow something close to Zero Covid is reached without it?) hospital workers need to follow this advice, too.

(What’s Left of) Our Economy: The Greatest Presidential Job Creator Ever?

Tags

Biden, Bureau of Labor Statistics, CCP Virus, coronavirus, COVID 19, Donald Trump, Employment, Jobs, lockdowns, NFP, non-farm payrolls, reopening, Wuhan virus, {What's Left of) Our Economy

However unwittingly, President Biden rendered the nation a major public service on Friday with his remarks on his administration’s achievements in boosting American job creation. Specifically, he provided a good indication of how many ways and how dramatically economic data can be spun.

According to the President, “we have added 6.4 million new jobs since January of last year — in one year. And that’s one of the most — that’s the most jobs in any calendar year by any president in history.”

A look at the data provided by the U.S. Bureau of Labor Statistics (BLS) shows that Mr. Biden actually slightly understated calendar 2021 overall net new job creation. Non-farm payrolls (BLS’ definition of the American employment universe) increased by 6.448 million during this period.

Mr. Biden’s focus on the calendar year, however, means that he’s taking credit for January. Not only wasn’t he inaugurated until January 20, but each month’s BLS job increase numbers cover the period between the middles of each month. (See the “Technical Note” section of each month’s report.) So the January job creation he’s claiming as his own stopped days before he entered office.

If it’s assumed that the current administration’s impact on employment (and the rest of the economy) didn’t start until the President took the Oath of Office – on a monthly basis, in February – then the employment increase that’s taken place on his watch so far is 6.215 million. That’s nearly 200,000 less than he claimed.

There’s no question that the employment picture orders of magnitude better than that of the last calendar year of the Trump administration – when non-farm payrolls cratered by 9.416 million.

At the same time, that calendar year includes the depths of the steep economic downturn induced by the CCP Virus’ arrival in the United States. In March and April, American employment levels crashdove by a sickening 22.362 million. And as should be remembered, including by those who view the Trump response to the pandemic itself as disastrously bad, this employment calamity mainly stemmed not from Trump economic policy decisions that presumably were inferior to their Biden administration counterparts. They mainly stemmed from health-related economic and behavioral restrictions that the former President supported only belatedly and reluctantly.

In fact, once the economy began reopening (raggedly, to be sure), job creation skyrocketed. From April, 2020 through January. 2021 – bringing the story up to just about the end of Trump’s presidency – NFP rose 12.575 million. That’s twice as much in absolute terms in nine months as in Mr. Biden’s 11 months in office.

As implied, though, this rapid improvement wasn’t mainly Trump’s doing. Clearly, economic stimulus measures helped. But far more important was a reopening and highly uneven return to economic normality. Moreover, because of the federal government’s limited authority over issues such as whether businesses closed altogether, or operate during limited hours, or how their customers should behave, the reopening decisions were overwhelmingly taken at the state and local level.

But as known by RealityChek regulars, President Biden’s remarks ignore a more fundamental concern: The kinds of absolute increases touted by President Biden are far from the whole story when it comes to judging economic performance, and can profoundly mislead even factoring out the whopping distortions of the economy created by the CCP Virus. At least as important are relative increases (or decreases) – in this case, because the size of the American workforce keeps changing.

And when the Biden job creation record is presented in terms of percentage increase, it doesn’t look so extraordinary at all. The Washington Post‘s Andrew Van Dam put it perfectly yesterday:

“The 6.4 million jobs gained this year, while a record in absolute terms, represents only a 4.5 percent increase in the workforce. That’s smaller than the 5.0 percent growth seen in 1978, when a much smaller labor force added 4.3 million jobs. In fact, relative to the size of the workforce, it’s only the 11th best calendar year since record-keeping began in 1939.”

Biden’s boasts about the economy certainly aren’t the first issuing from the Oval Office. Indeed, they’re no more exaggerated than TrumpWorld’s repeated claims that, pre-virus, he “helped America build its strongest economy in history.” But they’re also a needed reminder that whoever’s in office – a Democrat or Republican, an establishmentarian or a disrupter – their economic pronouncements are bound to deserve some Pinocchios.       

(What’s Left of) Our Economy: U.S. Manufacturing Job Creation Stands Out Again

Tags

aerospace, aircraft, aircraft engines, aircraft parts, CCP Virus, chemicals, coronavirus, COVID 19, Employment, Jobs, machinery, manufacturing, medical supplies, NFP, non-farm jobs, non-farm payrolls, non-metallic mineral products, Omicron variant, paper and paper products, personal protective equipment, pharmaceuticals, plastics and rubber products, PPE, private sector, semiconductor shortage, semiconductors, surgical equipment, vaccines, Wuhan virus, {What's Left of) Our Economy

Make that twice in a row. Just as in its November counterpart, the December official U.S. jobs data revealed sluggish overall American employment growth but better numbers for manufacturing. Even better, the gains were broad-based and the revisions of previous solid results were nicely positive.

A glass-half-empty type could rightly point out that industry’s 26,000 sequential payrolls gain last month was its weakest monthly result since April’s 35,000 employment drop. But the sector’s previously reported 31,000 sequential employment improvement is now pegged at 35,000. And after being downgraded from 60,000 to a (still-not-too shabby) 48,000, October’s increase has now been upgraded to 52,000.

For comparison’s sake, industry’s employment improvement came to 0.21 percent – as opposed to 0.17 percent for the private sector as a whole and 0.13 percent for “non-farm payrolls” (the U.S. Labor Department’s definition of the American employment universe).    

In fact, the December results continued a record of job out-performance that’s been consistent throughout the pandemic period.

As of December, manufacturers had replaced 84.19 percent (1.166 million) of the 1.385 million employees they’d shed during the short but steep CCP Virus-induced downturn of March and April, 2020. That figure’s 3.01 percent higher the 81.73 percent of regained jobs calculable from last month’s jobs report. Consequently, manufacturing payrolls are within 1.71 percent of their levels in February, 2020 – the last full data month before the pandemic began hammering and distorting the entire economy.

As for non-farm payrolls, they’ve now regained 84.02 percent (18.790 million) of the 22.362 million jobs lost during the worst of the pandemic. That’s 1.84 percent better than the 82.50 percent share calculable from last month’s jobs report. And there are now just 2.34 percent fewer non-farm U.S. jobs than in February, 2020.

As in the recent past, at first glance today it looks like the U.S. private sector has outdone manufacturing jobs-wise since the current economic rebound began. It’s recovered 87.61 percent (18.708 million) of its 21.353 million job loss during the spring of 2020. That’s 1.80 percent higher than the 86.06 percent figure calculable from the November jobs report. So it’s workforce is now 2.04 percent smaller than just before the pandemic.

But as known by RealityChek regulars, manufacturing’s jobs decline during that terrible spring of 2020 was smaller proportionately than that of the private or non-farm sectors. So even though it’s had less ground to make up, U.S.-based industry has been creating new employment at nearly the pace of the economy as a whole.

Indeed, just before the CCP Virus struck, manufacturing jobs represented 8.45 percent of total non-farm employment and 9.87 percent of private sector employment. As of December, these shares had risen to 8.45 percent and 9.90 percent, respectively.

The list of biggest jobs winners among the major manufacturing sub-sectors tracked by the Labor Department was headed by machinery – where payrolls rose by 7,000 on month in December. That was its biggest advance since July’s 8,700, and especially encouraging both because this industry lost 6,000 jobs in November (slightly better than the 7,000 decrease previously reported), and because its products are used throughout both manufacturing and big non-manufacturing industries like agriculture and construction.

Therefore, if machinery makers are adding strongly to their headcounts, they’re probably expecting demand for their goods to grow further. December’s hiring surge brought machinery employment to within 2.14 percent of its February, 2020 level.

Another major manufacturing employment gainer – automotive, where employment increased by 4,200 sequentially in December, and where the terrible 10,100 job loss reported last month for November is now judged to be just 5,900. As a result, payrolls in automotive – which remains dogged by the global semiconductor shortage – are now 5.28 percent lower than their immediate pre-pandemic levels.

Good December results were reported as well in the very big chemicals sector, which added 2,300 positions on month, and whose November performance was upgraded from no change to a 400-worker increase. Consequently, chemicals employment is now 1.30 percent greater than in February, 2020.

Other significant December manufacturing jobs winners included non-metallic mineral products (2,100) and plastics and rubber products (2,000).

The only manufacturing jobs loser that saw payrolls down by more than 1,000 was paper and paper products, where employment was off by 1,500. Even here, though, there was a somewhat bright side, as the decline was its first since July, and followed an upwardly revised 2,800 gain – its best since September, 2020’s 3,200. And this sub-sector’s employment levels are off just 1.84 percent since pre-pandemic-y February, 2020.

Given the aforementioned semiconductor shortage, however, it’s worth noting that December saw the semiconductors and electronic components industries (which, as the name suggests, includes more than just microchips), suffer their first back-to-back employment decline since March and April, 2020. The job reductions of 200 in November (upgraded from the previously reported 600) and 800 in December left employment levels 0.08 percent below those just before the CCP Virus struck.

As always, the most detailed employment data for pandemic-related industries are one month behind those in the broader categories, and their November job creation was mixed.

The surgical appliances and supplies sector, which contains personal protective equipment and similar goods, added 1,400 workers sequentially in November. And even though October net hiring remained unrevised at a small 100, these industries have now increased employment by 9.60 percent since February, 2020.

Yet the overall pharmaceuticals and medicines industry lost 600 jobs in November, after boosting employment by a downwardly revised 1,400 in October. Its workforce is now 5.27 percent larger than in February, 2020.

Much better results were turned in by the medicines subsector containing vaccines. October’s hiring gain was revised up from 700 to 800, and payrolls rose by another 1,400 in November. These advances have pushed these companies’ payrolls 14.66 higher than just before the pandemic’s arrival.

The mixed pattern continued in the aviation cluster, which has suffered both from aerospace giant Boeing’s manufacturing and safety problems and the pandemic’s restrictions on travel. Good news like the prospect of China allowing the troubled 737 Max model to return to its huge market reportedly have spurred the company to speed up a production rebound, and interestingly, U.S. aircraft employment climbed by 1,000 in November – the best monthly performance since July’s 4,700 jump.

But October’s previously reported small 300 jobs gain was revised down to 200, and with its workforce still 7.75 percent smaller than in February, 2020, aircraft employment’s comeback remains far from complete.

Moreover, the improving aircraft jobs picture doesn’t yet extend to aircraft suppliers. In aircraft engines and engine parts industry, October’s previously reported 100 job decline is now judged to be an increase of 100. But payrolls resumed shrinking in November (by 300), and employment in this sector is now off 13.93 percent since February, 2020.

In non-engine aircraft parts and equipment, employment was unchanged sequentially in November, but a jobs gain of 100 previously reported for October has now been downgraded to a job loss of 100. The bottom line? Its workforce is now 15.74 percent smaller than in February, 2020.

As has been so often the case, and like the rest of the economy, U.S. manufacturing faces perplexing – and in fact unprecedented crosswinds – going forward. And the uncertainties look all the more mysterious since these December jobs results pre-date the arrival of the wildly infectious Omicron variant of the CCP Virus – which could well lead to more health-related restrictions and behavioral changes, even tighter labor markets, and slower economic growth.

But unless Omicron prompts major, protracted shutdowns, manufacturing’s performance during the pandemic so far seems to justify optimism that industry will keep overcoming whatever obstacles come its way — whether policy or pathogens.

(What’s Left of) Our Economy: November Was an Awfully Cruel Month for U.S. Trade

Tags

Advanced Technology Products, Canada, CCP Virus, Census Bureau, China, coronavirus, COVID 19, European Union, exports, Federal Reserve, goods trade, imports, inflation, Japan, manufacturing, non-oil goods trade deficit, Omicron variant, services trade, stimulus, supply chains, Trade, trade deficit, Wuhan virus, {What's Left of) Our Economy

So maybe the global and especially U.S. supply chain snags of the last year are finally unraveling? That could well be a message being sent by this morning’s official release on American trade figures for November – which was dominated by huge increases in the nation’s goods imports, often to record levels.

Interestingly, though, little of this surge in goods from abroad came from China – probably reflecting some combination of the continuing effects of the Trump (and now Biden) tariffs, the ongoing semiconductor shortage that creates outsized problems for a country so reliant on electronics exports, and widespread power outages stemming from tight coal supplies.

Today’s report from the Census Bureau showed that the overall U.S. trade deficit swelled sequentially from $67.16 billion in October (the smallest since April’s $66.15 billion) to $80.17 billion. That total was the second largest ever (after September’s $81.44 billion). In addition, the 19.38 percent monthly increase was the most since July, 2020’s 19.87 percent. (The worst all-time relative month-to-month increase was 44.12 percent way back in December, 1996, when U.S. trade flows were much smaller, and therefore percentage increases much easier to generate.)

The November goods deficit of $98.99 billion was a record (topping the previous $97.83 billion all-time high of September), and the18.04 percent increase over October’s $83.86 level was the second greatest ever (after the 25.18 percent spurt of March, 2015 that resulted largely from a recovery after the previous month’s harsh winter weather).

Although November’s petroleum trade deficit more than quadrupled on month (to a still-modest $1.07 billion), the month’s shortfall in non-oil goods – the trade flows most influenced by U.S. trade policy decisions – soared by 17.06 percent, to $96.97 biillion. That total is a new record (eclipsing September’s $93.67 billion), and the increase was the biggest since the record 31.24 percent also set in March, 2015.

The roughly $13 billion absolute monthly rise in the November overall trade deficit resulted entirely (and then some) from combined goods and services imports, which were up $13.44 billion. The month’s $304.89 billion total was a second straight record (besting October’s $291.04 billion), and the 4.60 percent increase the biggest since March’s 7.18 percent. (The record relative total monthy import incease was July, 2020’s 10.58 percent.)

The story was similar in goods imports. They, too, set a second straight record, with the $254.93 billion level 5.05 percent higher than October’s previous all-time high of $242.67 billion, and the rate of increase the fastest since March’s 7.73 percent. (This record, too, was set in July 2020 – at 11.93 percent).

Continuing November’s string of consecutive all-time highs was the non-oil goods category of imports. At $232.30 billion, these purchases broke October’s previous record of $221.82 billion by 4.73 percent, a relative rise that was the fastest since March (7.12 percent). Their fastest increase came in July, 2020, too (11.88 percent). 

As indicated earlier, though, goods trade with China departed from this pattern. These imports advanced as well – but by just 0.73 percent. Their $48.39 billion level was the year’s highest, but only slightly above October’s $48.03 billion. Moreover, though elevated, these inflows fell short of the record $52.08 billion in October, 2018 – when U.S. companies were “front-running” their China purchases to bring them into the country before steep tariffs kicked in.

Moreover, the $32.32 billion goods deficit with China was far from the high for the year (September’s $36.50 billion), much less anywhere close to the monthly record ($42.89 billion, which also came in October, 2018).

So geographically speaking, where did U.S. goods deficits go up the most month-to-month in November? Among the nation’s biggest trade partners, Canada was the biggest culprit percentage-wise. America’s $6.12 billion of goods purchases from its northern neighbor were the most of 2021 and the biggest such total since September, 2008’s $7.36 billion. And the sequential leap of 60.67 percent (which, to be fair, followed a big October decline of 26.09 percent) was the fastest since January, 2021’s 74.04 percent surge.

The goods deficit with the European Union was up 28.59 percent sequentially in November to a record $20.85 billion. The increase, moreover, was the greatest since the 73.82 percent rate of March, 2020, as Europe was climbing out of its first CCP Virus wave.

And the goods gap was up by 17.74 percent with Japan to $4.16 billion. The total was the year’s second lowest (after February’s $4.02 billion) but the increase was the fastest since July’s 27.43 percent (though it followed a 23.21 percent plunge in October).

Turning to specific products, more new trade records came in the manufacturing sector. The November trade deficit for industry hit a new all-time high of $124.06 billion – a total that broke the old mark (September’s $118.75 billion) by 8.06 percent. Manufacturing exports sank sequentially in November by 4.15 percent, from $102.752 billion to $98.488 billion, and the 2.29 percent increase in manufacturing exports brought them to their second straight monthly worst – $222.553 billion.

With one month left in data year 2021, the manufacturing trade deficit stands at $1.209 trillion, and is running 11.63 percent ahead of 2020’s record rate.

Not that the records stop with manufactures. In Advanced Technology Products, imports of $52.52 billion set their third staight all-time high, and the November deficit of $21.76 billion trailed only November, 2020’s $21.90 billion in this data series’ 33-year history.

One positive all-time trade high was set in November: At $224.22 billion, total exports established their second record monthly total. But the monthly improvement was a measly 0.16 percent.

November’s $155.94 billion worth of goods exports were the second highest monthly total on record – but the level was down 1.81 percent sequentially.

The pandemic-beleaguered services sector delivered some good trade news, too. Its longstanding trade surplus remains low by historic standards, but did climb by 12.68 percent, to $18.82 billion. The increase was the fastest since the 28.08 percent recorded in September, 2004 (when services trade flows were much smaller than today’s), and the total was the best since June’s $20.33 billion.

Services exports enjoyed a strong November, too. They hit $68.27 billion, for their highest mark since the $69.12 billion reached in February, 2020 – just before the pandemic arrived in the United States and began seriously distorting its trade flows and entire economy. Further, the 4.97 percent improvement was the best since January, 2002’s 5.56 percent.

Will November prove to be the cruelest month – at least for the time being – for U.S. trade? A further removal of supply chain bottlenecks and the huge savings still amassed by American consumers say “No.” But the opposite conclusion could easily be reached by pointing to a reduction in the Federal Reserve’s economic stimulus programs, the unlikelihood of Congress approving big spending bills during this midterm election year, and still lofty inflation rates – which at some point will produce a consumer pullback.

The impact of the CCP Virus, it’s highly infectious Omicron variant, and possible future strains? Those are the $64,000 questions that trade and economic policy analysis may well find excruciatingly difficult to answer.

Following Up: Podcast Now On-Line of National Radio Interview on China and Supply Chains

Tags

CBS Eye on the World with John Batchelor, CCP Virus, China, coronavirus, COVID 19, Following Up, global supply chains, globalization, John Batchelor, logistics, manufacturing, supply chains, transportation, Wuhan virus, zero covid policy

I’m pleased to announce that the podcast is now on-line of my interview last night on the nationally syndicated “CBS Eye on the World with John Batchelor.”

Click here for a timely discussion of whether the continuing and multiple snags in many China-centered global supply chains will prompt U.S. and other foreign-owned companies to hedge their production bets by cutting their reliance on Chinese operations.

And keep checking in with RealityChek for news of upcoming media appearances and other developments

Making News: Back on National Radio on Chinese Manufacturing and U.S. Supply Chain Security

Tags

CBS Eye on the World with John Batchelor, CCP Virus, China, coronavirus, COVID 19, Gordon G. Chang, John Batchelor, Making News, manufacturing, supply chains, Wuhan virus, zero covid policy

I’m pleased to announce that tonight I’m scheduled to be back on the nationally syndicated “CBS Eye on the World with John Batchelor.” Air time for the segment is yet to be determined, but the show is on nightly between 9 PM and 1 AM EST, and you can listen live by visiting this link and clicking on the red button at the top center. 

On the agenda for John, co-host Gordon G. Chang, and me:  the outlook for China’s gigantic manufacturing sector – and how much of it will leave for the  United States and elsewhere to bolster supply chain resilience.

As usual, if you can’t tune in, the podcast will be posted as soon as it’s on-line.

And keep checking in with RealityChek for news of upcoming media appearances and other developments.

(What’s Left of) Our Economy: Could the “Great Resignation” be Ending?

Tags

CCP Virus, coronavirus, COVID 19, Employment, Great Resignation, Jobs, JOLTS, labor market, labor shortages, quits, quits rate, transitory, workers, Wuhan virus, {What's Left of) Our Economy

The Labor Department’s monthly “JOLTS” report is one of the official U.S. economic data series that I stopped covering during the CCP Virus era. After all, the results seemed to be so overwhelmingly driven by pandemic-specific disruptions, and therefore so unrelated to the fundamental state of the U.S. economy.

I’m still wary of putting too much stock in JOLTS, which stands for Job Openings and Labor Turnover Survey. As the name suggests, it tracks how many positions at American businesses (including in government) are vacant, how many workers are quitting, how many are getting fired or laid off, and how many are getting hired, and it’s one of the key sets of statistics that have revealed both the extent of the labor shortages marking the economy and of what’s been called the “Great Resignation” – a major and indeed record increase in the numbers and percentages of workers voluntarily leaving their employers.

Yet since this development has so clearly (at least to me) stemmed from pandemicky circumstances, I assumed that it would turn out to be largely “transitory” (to use the Federal Reserve’s now “retired” description of elevated inflation).

So why this JOLTS-y post? Because this morning’s latest report, which takes the story through November, does show signs of normalization in those jobs quits. To be sure, the absolute numbers of quits hit yet another record – 4.527 million. In fact, that total represents the seventh straight month in which this quits level topped the pre-CCP Virus high of 3.627 million, set in July, 2019.

As known by RealityChek regulars, though, absolute numbers don’t provide the entire, or even the most important parts of, a picture. In this case, that’s because the numbers of employed Americans have grown substantially since the JOLTS series began at the end of 2000. What matters more is the quits rate – the percentage of the employed leaving their positions.

For non-farm workers (the Labor Department’s U.S. employment universe), this rate, at three percent in November, is still well above the pre-pandemic high of 2.4 percent – which also came in 2019 (in February, July, and August), as well as in April, 2001. But it’s barely risen on net since April’s 2.8 percent.

For private sector workers, the recent quits rates movement is less dramatic, and that’s more important for judging the transitory-ness of the Great Resignation – because the private sector is much bigger than the public, and the trends shaping it are much more reflective of market forces, not politicians’ decisions.

But it still seems worth noting that even though it rose to a record 3.4 percent in November (significantly higher than the pre-pandemic record 2.8 percent, set back in January, 2001, the private sector quits rate has been pretty stable since coming in at 3.3 percent in August.

Two caveats need to be mentioned, though. First, these November results are preliminary. Second, they predate the arrival in the United States of the CCP Virus’ highly infectious Omicron variant, which threatens to roil labor markets once again for the foreseeable future. One thing’s for sure – it’s time for me to renew monitoring these JOLTS reports!